Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 105 Carcinoma, Hepatocellular 34 Neoplasm Metastasis 19 Neoplasms 17 Gastrointestinal Stromal Tumors 17 Colonic Neoplasms 14 Rectal Neoplasms 12 Liver Neoplasms 8 Glioblastoma 7 Sarcoma 6 Stomach Neoplasms 5 Sarcoma, Ewing 5 Ovarian Neoplasms 5 Osteosarcoma 5 Melanoma 5 Cholangiocarcinoma 5 Adenocarcinoma 5 Pancreatic Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Non-Small-Cell Lung 4 Small Cell Lung Carcinoma 3 Rhabdomyosarcoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Leukemia, Myeloid, Acute 3 Colorectal Cancer Metastatic 3 Carcinoma, Transitional Cell 3 Carcinoma 3 Advanced Colorectal Cancer 3 Thyroid Neoplasms 2

Interventions

Magnetic Resonance Spectroscopy 16 Hydroxyurea 7 Everolimus 7 Bevacizumab 7 lutetium Lu 177 dotatate 6 gallium Ga 68 dotatate 6 Radiosurgery 6 Proton Therapy 6 Specimen Handling 5 pembrolizumab 4 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Radiotherapy 4 Imatinib Mesylate 4 Cyclophosphamide 4 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4 aldesleukin 3 abemaciclib 3 Tranexamic Acid 3 Temozolomide 3 Sunitinib 3 Sodium Chloride 3 Radiotherapy, Intensity-Modulated 3 Observation 3 Nivolumab 3 Ga(III)-DOTATOC 3 90Y-octreotide, DOTA-Tyr(3)- 3 vistusertib 2 trametinib 2 ribociclib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Meningioma × regorafenib × Clear all

NCT06275919 2026-05-13

MIRAGE

Istituto Oncologico Veneto IRCCS

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡